Global Pimozide Market Size, Trends, Insights, Growth and Forecast 2018 to 2025

The “Global Pimozide Market” is an in depth study analyzing the current state and forecast 2018-2025. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Global Pimozide Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Global Pimozide Market discusses the opportunity areas for investors.
The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Download Sample Copy Of This Report From Here: http://www.amecoresearch.com/sample/9078

This research report categorizes the global Pimozide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

The global average price of Pimozide is in the increasing trend, from 1.13 USD/Unit in 2013 to 1.19 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Pimozide includes 1Mg, 2Mg, 4Mg, and the proportion of 2Mg in 2017 is about 53%.

Pimozide is widely used in hospitals, drugstores and other places. The most proportion of Pimozide is used for hospitals in 2017 is 54%.

In 2017, the global Pimozide market size was 12 million US$ and is forecast to 11 million US in 2025, growing at a CAGR of -0.9% from 2018. The objectives of this study are to define, segment, and project the size of the Pimozide market based on company, product type, application and key regions.

The various contributors involved in the value chain of Pimozide include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Pimozide include
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma

View Detail Report With Complete Table of Content@ http://www.amecoresearch.com/market-report/global-pimozide-market-insights-forecast-to-2025-9078

Market Size Split by Type
1Mg
2Mg
4Mg
Market Size Split by Application
Hospitals
Drugstores
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

Table of Contents

Global Pimozide Market Insights, Forecast to 2025

1 Study Coverage
1.1 Pimozide Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pimozide Market Size Growth Rate by Type
1.4.2 1Mg
1.4.3 2Mg
1.4.4 4Mg
1.5 Market by Application
1.5.1 Global Pimozide Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Drugstores
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Pimozide Market Size
2.1.1 Global Pimozide Revenue 2016-2025
2.1.2 Global Pimozide Sales 2016-2025
2.2 Pimozide Growth Rate by Regions
2.2.1 Global Pimozide Sales by Regions
2.2.2 Global Pimozide Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Pimozide Sales by Manufacturers
3.1.1 Pimozide Sales by Manufacturers
3.1.2 Pimozide Sales Market Share by Manufacturers
3.1.3 Global Pimozide Market Concentration Ratio (CR5 and HHI)
3.2 Pimozide Revenue by Manufacturers
3.2.1 Pimozide Revenue by Manufacturers (2016-2018)
3.2.2 Pimozide Revenue Share by Manufacturers (2016-2018)
3.3 Pimozide Price by Manufacturers
3.4 Pimozide Manufacturing Base Distribution, Product Types
3.4.1 Pimozide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pimozide Product Category
3.4.3 Date of International Manufacturers Enter into Pimozide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Pimozide Sales by Type
4.2 Global Pimozide Revenue by Type
4.3 Pimozide Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Pimozide Breakdown Data by Application

6 North America
6.1 North America Pimozide by Countries
6.1.1 North America Pimozide Sales by Countries
6.1.2 North America Pimozide Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pimozide by Type
6.3 North America Pimozide by Application
6.4 North America Pimozide by Company

7 Europe
7.1 Europe Pimozide by Countries
7.1.1 Europe Pimozide Sales by Countries
7.1.2 Europe Pimozide Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pimozide by Type
7.3 Europe Pimozide by Application
7.4 Europe Pimozide by Company

8 Asia Pacific
8.1 Asia Pacific Pimozide by Countries
8.1.1 Asia Pacific Pimozide Sales by Countries
8.1.2 Asia Pacific Pimozide Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pimozide by Type
8.3 Asia Pacific Pimozide by Application
8.4 Asia Pacific Pimozide by Company

9 Central & South America
9.1 Central & South America Pimozide by Countries
9.1.1 Central & South America Pimozide Sales by Countries
9.1.2 Central & South America Pimozide Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pimozide by Type
9.3 Central & South America Pimozide by Application
9.4 Central & South America Pimozide by Company

10 Middle East and Africa
10.1 Middle East and Africa Pimozide by Countries
10.1.1 Middle East and Africa Pimozide Sales by Countries
10.1.2 Middle East and Africa Pimozide Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pimozide by Type
10.3 Middle East and Africa Pimozide by Application
10.4 Middle East and Africa Pimozide by Company

11 Company Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Pimozide
11.1.4 Pimozide Product Description
11.1.5 Recent Development
11.2 Par Pharmaceutical
11.2.1 Par Pharmaceutical Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Pimozide
11.2.4 Pimozide Product Description
11.2.5 Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Pimozide
11.3.4 Pimozide Product Description
11.3.5 Recent Development
11.4 Eumedica
11.4.1 Eumedica Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Pimozide
11.4.4 Pimozide Product Description
11.4.5 Recent Development
11.5 Pharmascience
11.5.1 Pharmascience Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Pimozide
11.5.4 Pimozide Product Description
11.5.5 Recent Development
11.6 Domina Pharmaceuticals
11.6.1 Domina Pharmaceuticals Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Pimozide
11.6.4 Pimozide Product Description
11.6.5 Recent Development
11.7 Aa Pharma
11.7.1 Aa Pharma Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Pimozide
11.7.4 Pimozide Product Description
11.7.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Pimozide Raw Material
13.1.2 Pimozide Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/9078

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Call: + 1 407 915 4157 | Email: sales@amecoresearch.com

This release was published on openPR.